PubMed

Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.

Kern TS, Engerman RL.

Diabetes. 2001 Jul;50(7):1636-42.PMID: 11423486 [PubMed - indexed for MEDLINE]Related articlesFree article

Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.PMID: 11053301 [PubMed - indexed for MEDLINE]Related articlesFree article

Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.

Degenhardt TP, Fu MX, Voss E, Reiff K, Neidlein R, Strein K, Thorpe SR, Baynes JW, Reiter R.

Diabetes Res Clin Pract. 1999 Feb;43(2):81-9.PMID: 10221660 [PubMed - indexed for MEDLINE]Related articles

Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug.

Gardiner TA, Anderson HR, Degenhardt T, Thorpe SR, Baynes JW, Archer DB, Stitt AW.

Diabetologia. 2003 Sep;46(9):1269-75. Epub 2003 Jul 12.PMID: 12861449 [PubMed - indexed for MEDLINE]Related articles

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.

Hammes HP, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K.

Diabetologia. 1994 Jan;37(1):32-5.PMID: 8150227 [PubMed - indexed for MEDLINE]Related articles

Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.

Gardiner TA, Anderson HR, Stitt AW.

J Pathol. 2003 Oct;201(2):328-33.PMID: 14517851 [PubMed - indexed for MEDLINE]Related articles

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M.

Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11555-8. Erratum in: Proc Natl Acad Sci U S A 1992 Oct 1;89(19):9364. PMID: 1763069 [PubMed - indexed for MEDLINE]Related articlesFree article

Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.

Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS.

Diabetes. 2007 Feb;56(2):337-45. Erratum in: Diabetes. 2007 May;56(5):1486. PMID: 17259377 [PubMed - indexed for MEDLINE]Related articlesFree article

Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects.

Sun W, Gerhardinger C, Dagher Z, Hoehn T, Lorenzi M.

Diabetes. 2005 Dec;54(12):3418-26.PMID: 16306357 [PubMed - indexed for MEDLINE]Related articlesFree article

Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.

Hammes HP, Strödter D, Weiss A, Bretzel RG, Federlin K, Brownlee M.

Diabetologia. 1995 Jun;38(6):656-60.PMID: 7672485 [PubMed - indexed for MEDLINE]Related articles

Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.

Kowluru RA, Engerman RL, Kern TS.

Curr Eye Res. 2000 Oct;21(4):814-9.PMID: 11120572 [PubMed - indexed for MEDLINE]Related articles

Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.

Agardh E, Hultberg B, Agardh C.

Curr Eye Res. 2000 Jul;21(1):543-9.PMID: 11035534 [PubMed - indexed for MEDLINE]Related articles

Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP.

Diabetes. 2007 Feb;56(2):373-9.PMID: 17259381 [PubMed - indexed for MEDLINE]Related articlesFree article

Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.

Du Y, Sarthy VP, Kern TS.

Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R735-41.PMID: 15371279 [PubMed - indexed for MEDLINE]Related articles

Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.

Nyengaard JR, Chang K, Berhorst S, Reiser KM, Williamson JR, Tilton RG.

Diabetes. 1997 Jan;46(1):94-106.PMID: 8971088 [PubMed - indexed for MEDLINE]Related articles

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR.

Diabetes. 2002 Sep;51(9):2826-32. Erratum in: Diabetes 2003 Jan;52(1):223. Anderson Nathan L [corrected to Alderson Nathan L]. PMID: 12196477 [PubMed - indexed for MEDLINE]Related articlesFree article

Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.

Roufail E, Soulis T, Boel E, Cooper ME, Rees S.

Diabetologia. 1998 Dec;41(12):1419-25.PMID: 9867208 [PubMed - indexed for MEDLINE]Related articles

Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.

Hammes HP, Ali SS, Uhlmann M, Weiss A, Federlin K, Geisen K, Brownlee M.

Diabetologia. 1995 Mar;38(3):269-73.PMID: 7758871 [PubMed - indexed for MEDLINE]Related articles

Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine.

Hammes HP, Bartmann A, Engel L, Wülfroth P.

Diabetologia. 1997 Jun;40(6):629-34.PMID: 9222640 [PubMed - indexed for MEDLINE]Related articles

Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.

Kern TS, Engerman RL.

Curr Eye Res. 1994 Dec;13(12):863-7.PMID: 7720392 [PubMed - indexed for MEDLINE]Related articles